127 related articles for article (PubMed ID: 27802432)
1. Characterization of the Anticoagulant and Antithrombotic Properties of the Sphingosine 1-Phosphate Mimetic FTY720.
Zhao Z; Wang R; Huo Z; Li C; Wang Z
Acta Haematol; 2017; 137(1):1-6. PubMed ID: 27802432
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
3. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
Hamidi Shishavan M; Bidadkosh A; Yazdani S; Lambooy S; van den Born J; Buikema H; Henning RH; Deelman LE
PLoS One; 2016; 11(9):e0162029. PubMed ID: 27583547
[TBL] [Abstract][Full Text] [Related]
5. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
6. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
7. The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
Gao F; Gao Y; Meng F; Yang C; Fu J; Li Y
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):14-20. PubMed ID: 29380527
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic effects and related mechanisms of Salvia deserta Schang root EtOAc extracts.
Kasimu R; Wang X; Wang X; Hu J; Wang X; Mu Y
Sci Rep; 2018 Dec; 8(1):17753. PubMed ID: 30532017
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Li C; Li JN; Kays J; Guerrero M; Nicol GD
J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
[TBL] [Abstract][Full Text] [Related]
10. Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage.
Hasegawa Y; Uekawa K; Kawano T; Suzuki H; Kim-Mitsuyama S
Curr Drug Deliv; 2017 Sep; 14(6):861-866. PubMed ID: 27605019
[TBL] [Abstract][Full Text] [Related]
11. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
12. Anti-thrombotic activity of PDR, a newly synthesized L-Arg derivative, on three thrombosis models in rats.
Tang Z; Wang Y; Xiao Y; Zhao M; Peng S
Thromb Res; 2003 May; 110(2-3):127-33. PubMed ID: 12893027
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
Lockyer S; Kambayashi J
J Cardiovasc Pharmacol; 1999 May; 33(5):718-25. PubMed ID: 10226858
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
Coldewey SM; Benetti E; Collino M; Pfeilschifter J; Sponholz C; Bauer M; Huwiler A; Thiemermann C
Sci Rep; 2016 Jun; 6():27594. PubMed ID: 27277195
[TBL] [Abstract][Full Text] [Related]
15. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulator FTY720 is phosphorylated and released from platelets.
Anada Y; Igarashi Y; Kihara A
Eur J Pharmacol; 2007 Jul; 568(1-3):106-11. PubMed ID: 17553484
[TBL] [Abstract][Full Text] [Related]
18. The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Egom EE; Kruzliak P; Rotrekl V; Lei M
J Cell Mol Med; 2015 Jul; 19(7):1729-34. PubMed ID: 25864579
[TBL] [Abstract][Full Text] [Related]
19. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
Kolahdooz Z; Nasoohi S; Asle-Rousta M; Ahmadiani A; Dargahi L
Can J Neurol Sci; 2015 May; 42(3):195-202. PubMed ID: 25860537
[TBL] [Abstract][Full Text] [Related]
20. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
